Author
Listed:
- Nicla Porciello
(Sapienza University)
- Paola Grazioli
(Sapienza University)
- Antonio F. Campese
(Sapienza University)
- Martina Kunkl
(Sapienza University)
- Silvana Caristi
(Sapienza University)
- Marta Mastrogiovanni
(Sapienza University)
- Michela Muscolini
(Istituto Pasteur-Fondazione Cenci Bolognetti)
- Francesca Spadaro
(Istituto Superiore di Sanità)
- Cédric Favre
(Aix-Marseille Université UM 105
Immunotech SAS)
- Jacques A. Nunès
(Aix-Marseille Université UM 105)
- Aldo Borroto
(Spanish National Research Council-Autonomous University of Madrid (CSIC-UAM))
- Balbino Alarcon
(Spanish National Research Council-Autonomous University of Madrid (CSIC-UAM))
- Isabella Screpanti
(Sapienza University)
- Loretta Tuosto
(Sapienza University)
Abstract
CD28 superagonistic antibodies (CD28SAb) can preferentially activate and expand immunosuppressive regulatory T cells (Treg) in mice. However, pre-clinical trials assessing CD28SAbs for the therapy of autoimmune diseases reveal severe systemic inflammatory response syndrome in humans, thereby implying the existence of distinct signalling abilities between human and mouse CD28. Here, we show that a single amino acid variant within the C-terminal proline-rich motif of human and mouse CD28 (P212 in human vs. A210 in mouse) regulates CD28-induced NF-κB activation and pro-inflammatory cytokine gene expression. Moreover, this Y209APP212 sequence in humans is crucial for the association of CD28 with the Nck adaptor protein for actin cytoskeleton reorganisation events necessary for CD28 autonomous signalling. This study thus unveils different outcomes between human and mouse CD28 signalling to underscore the importance of species difference when transferring results from preclinical models to the bedside.
Suggested Citation
Nicla Porciello & Paola Grazioli & Antonio F. Campese & Martina Kunkl & Silvana Caristi & Marta Mastrogiovanni & Michela Muscolini & Francesca Spadaro & Cédric Favre & Jacques A. Nunès & Aldo Borroto , 2018.
"A non-conserved amino acid variant regulates differential signalling between human and mouse CD28,"
Nature Communications, Nature, vol. 9(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03385-8
DOI: 10.1038/s41467-018-03385-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03385-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.